AUTISM SPEAKS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2005-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.autismspeaks.org/
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Developmental and Augmented Intervention for Facilitating Expressive Language
Not Applicable
Completed
- Conditions
- Joint Engagement + Enhanced Milieu TrainingJoint Engagement + Enhanced Milieu Training+Augmentative Communication (AAC)
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Autism Speaks
- Target Recruit Count
- 96
- Registration Number
- NCT01013545
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Kennedy Krieger Institute, Baltimore, Maryland, United States
🇺🇸Vanderbilt University, Nashville, Tennessee, United States
Promoting Development in Toddlers With Communication Delays
Not Applicable
Completed
- Conditions
- Autism Spectrum Disorder
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Autism Speaks
- Target Recruit Count
- 60
- Registration Number
- NCT01012076
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Hunter College, New York, New York, United States
News
LinusBio and Autism Speaks Join Forces to Accelerate Early Autism Diagnosis Through Hair Biomarker Test
LinusBio and Autism Speaks have partnered to promote ClearStrand-ASD, a first-in-class biochemical test that identifies autism biomarkers in hair strands of infants and toddlers aged 1-36 months.